Ekachai Medical Care Valuation
Is EKH-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EKH-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EKH-R (THB6.35) is trading above our estimate of fair value (THB4.53)
Significantly Below Fair Value: EKH-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EKH-R?
Other financial metrics that can be useful for relative valuation.
What is EKH-R's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿4.94b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 3.2x |
Enterprise Value/EBITDA | 10.2x |
PEG Ratio | 2.5x |
Price to Earnings Ratio vs Peers
How does EKH-R's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 18.9x | ||
NTV Nonthavej Hospital | 13.6x | n/a | ฿5.3b |
TNH Thai Nakarin Hospital | 14.4x | n/a | ฿6.3b |
PHG Patrangsit Healthcare Group | 17.8x | 11.2% | ฿5.0b |
CMR Chiang Mai Ram Medical Business | 29.8x | n/a | ฿7.2b |
EKH-R Ekachai Medical Care | 18x | 7.1% | ฿4.9b |
Price-To-Earnings vs Peers: EKH-R is good value based on its Price-To-Earnings Ratio (18x) compared to the peer average (18.9x).
Price to Earnings Ratio vs Industry
How does EKH-R's PE Ratio compare vs other companies in the TH Healthcare Industry?
Price-To-Earnings vs Industry: EKH-R is good value based on its Price-To-Earnings Ratio (18x) compared to the TH Healthcare industry average (22.2x).
Price to Earnings Ratio vs Fair Ratio
What is EKH-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 18x |
Fair PE Ratio | 18.2x |
Price-To-Earnings vs Fair Ratio: EKH-R is good value based on its Price-To-Earnings Ratio (18x) compared to the estimated Fair Price-To-Earnings Ratio (18.2x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.